Is anti-tumor necrosis factor therapy effective in reducing uveitis flares in patients with spondyloarthropathies?
Levy-Clarke
Grace
G
Uveitis and Ocular Immunology Fellowship, Biometry Branch, and the Laboratory of Immunology, National Eye Institute, NIH, Bethesda, MD 20892, USA. clarkeg@nei.nih.gov
Reed
George
G
Nussenblatt
Robert
R